Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyadharshni Muniyandi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|March 29, 2020
Direct Cardiac Reprogramming with Engineered miRNA ScaffoldsPriyadharshni Muniyandi, Toru Maekawa, Tatsuro Hanajiri, et al.
International Journal of Molecular Sciences|December 11, 2022
Direct Cardiac Epigenetic Reprogramming through Codelivery of 5'Azacytidine and miR-133a NanoformulationPriyadharshni Muniyandi, Vivekanandan Palaninathan, Tatsuro Hanajiri, et al.
International Journal of Pharmaceutics|September 22, 2018
Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approachSrishti Agarwal, Priyadharshni Muniyandi, Toru Maekawa, et al.
Frontiers in Bioengineering and Biotechnology|August 10, 2023
Biotechnological advances and applications of human pluripotent stem cell-derived heart modelsPriyadharshni Muniyandi, Colin O'Hern, Mirel Adrian Popa, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 3, 2021
Scaffold mediated delivery of dual miRNAs to transdifferentiate cardiac fibroblastsPriyadharshni Muniyandi, Vivekanandan Palaninathan, Toru Mizuki, et al.
Polymers|February 21, 2020
ECM Mimetic Electrospun Porous Poly (L-lactic acid) (PLLA) Scaffolds as Potential Substrates for Cardiac Tissue EngineeringPriyadharshni Muniyandi, Vivekanandan Palaninathan, Srivani Veeranarayanan, et al.
STAR Protocols|March 6, 2026
Protocol to generate immunocompetent human heart-macrophage assembloids for the study of immune-cardiac interactionsColin O'Hern, Mia Dionise, Sammantha Caywood, et al.
Nature Communications|December 12, 2023
A patterned human primitive heart organoid model generated by pluripotent stem cell self-organizationBrett Volmert, Artem Kiselev, Aniwat Juhong, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Human heart assembloids with autologous tissue-resident macrophages recreate physiological immuno-cardiac interactionsColin O'Hern, Sammantha Caywood, Shakhlo Aminova, et al.
Cell Stem Cell|October 28, 2025
Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modelingColin O'Hern, Sammantha Caywood, Shakhlo Aminova, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|March 29, 2020
Direct Cardiac Reprogramming with Engineered miRNA ScaffoldsPriyadharshni Muniyandi, Toru Maekawa, Tatsuro Hanajiri, et al.
International Journal of Molecular Sciences|December 11, 2022
Direct Cardiac Epigenetic Reprogramming through Codelivery of 5'Azacytidine and miR-133a NanoformulationPriyadharshni Muniyandi, Vivekanandan Palaninathan, Tatsuro Hanajiri, et al.
International Journal of Pharmaceutics|September 22, 2018
Vesicular systems employing natural substances as promising drug candidates for MMP inhibition in glioblastoma: A nanotechnological approachSrishti Agarwal, Priyadharshni Muniyandi, Toru Maekawa, et al.
Frontiers in Bioengineering and Biotechnology|August 10, 2023
Biotechnological advances and applications of human pluripotent stem cell-derived heart modelsPriyadharshni Muniyandi, Colin O'Hern, Mirel Adrian Popa, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 3, 2021
Scaffold mediated delivery of dual miRNAs to transdifferentiate cardiac fibroblastsPriyadharshni Muniyandi, Vivekanandan Palaninathan, Toru Mizuki, et al.
Polymers|February 21, 2020
ECM Mimetic Electrospun Porous Poly (L-lactic acid) (PLLA) Scaffolds as Potential Substrates for Cardiac Tissue EngineeringPriyadharshni Muniyandi, Vivekanandan Palaninathan, Srivani Veeranarayanan, et al.
STAR Protocols|March 6, 2026
Protocol to generate immunocompetent human heart-macrophage assembloids for the study of immune-cardiac interactionsColin O'Hern, Mia Dionise, Sammantha Caywood, et al.
Nature Communications|December 12, 2023
A patterned human primitive heart organoid model generated by pluripotent stem cell self-organizationBrett Volmert, Artem Kiselev, Aniwat Juhong, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Human heart assembloids with autologous tissue-resident macrophages recreate physiological immuno-cardiac interactionsColin O'Hern, Sammantha Caywood, Shakhlo Aminova, et al.
Cell Stem Cell|October 28, 2025
Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modelingColin O'Hern, Sammantha Caywood, Shakhlo Aminova, et al.
Pageof 1